![](/img/cover-not-exists.png)
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
M. Mehta, M. Wang, K. Aldape, E. Sulman, R. Stupp, K. Jaeckle, D. Blumenthal, S. Erridge, W. Curran, M. GilbertVolume:
47
Year:
2011
Language:
english
DOI:
10.1016/s0959-8049(11)70117-4
File:
PDF, 52 KB
english, 2011